COVID-19住院患者继发感染的发生率及预测因素
该队列研究纳入2020年2月25日至4月6日在IRCCS San Raffaele医院住院的731例COVID-19患者,继发感染诊断68例(9.3%),28天累积发生率16.4%(95%CI 12.4-21.0%)。多因素分析显示基线低淋巴细胞计数、低PaO2/FiO2及48小时内入住ICU与继发感染风险相关。
要点
- COVID-19住院患者继发感染发生率较高,28天累积发生率达16.4%。
- 继发血流感染以革兰阳性菌为主,其中凝固酶阴性葡萄球菌占69.7%。
- 低淋巴细胞计数、低PaO2/FiO2及早期ICU入住是继发感染的预测因素。
核心结论
- COVID-19住院患者继发感染发生率高,早期需ICU、呼吸衰竭和严重淋巴细胞减少是继发感染的危险因素。
研究设计与样本
- 这是一项队列研究,纳入2020年2月25日至4月6日在IRCCS San Raffaele医院住院的731例COVID-19患者(NCT04318366)。
主要发现
- 68/731例(9.3%)诊断为继发感染,58/731例(7.9%)至少一次血流感染,22/731例(3.0%)至少一次可能下呼吸道感染。
- 28天累积发生率为16.4%(95%CI 12.4-21.0%)。
- 血流感染以革兰阳性菌为主(76/106株,71.7%),其中凝固酶阴性葡萄球菌53/76株(69.7%);革兰阴性菌23/106株(21.7%),以鲍曼不动杆菌7/23株(30.4%)和大肠埃希菌5/23株(21.7%)为主。
- 可能下呼吸道感染主要由革兰阴性菌引起(14/26株,53.8%),11例诊断为疑似侵袭性曲霉病。
- 多因素分析显示基线淋巴细胞计数≤0.7 vs >0.7×10^9/L的sdHR为1.93(95%CI 1.11-3.35),基线PaO2/FiO2每低100点的sdHR为1.56(95%CI 1.21-2.04),48小时内入住ICU的sdHR为2.51(95%CI 1.04-6.05)。
临床怎么用
- 对COVID-19住院患者应关注继发感染风险,尤其是基线淋巴细胞低、氧合差或早期需ICU者。
- 继发血流感染经验性覆盖需考虑革兰阳性菌,尤其是凝固酶阴性葡萄球菌。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The aim of our study was to describe the incidence and predictive factors of secondary infections in patients with coronavirus disease 2019 (COVID-19). METHODS: This was a cohort study of patients hospitalized with COVID-19 at IRCCS San Raffaele Hospital between 25th February and 6th April 2020 (NCT04318366). We considered secondary bloodstream infections (BSIs) or possible lower respiratory tract infections (pLRTIs) occurring 48 hours after hospital admission until death or discharge. We calculated multivariable Fine-Gray models to assess factors associated with risk of secondary infections. RESULTS: Among 731 patients, a secondary infection was diagnosed in 68 patients (9.3%); 58/731 patients (7.9%) had at least one BSI and 22/731 patients (3.0%) at least one pLRTI. The overall 28-day cumulative incidence was 16.4% (95%CI 12.4-21.0%). Most of the BSIs were due to Gram-positive pathogens (76/106 isolates, 71.7%), specifically coagulase-negative staphylococci (53/76, 69.7%), while among Gram-negatives (23/106, 21.7%) Acinetobacter baumanii (7/23, 30.4%) and Escherichia coli (5/23, 21.7%) predominated. pLRTIs were caused mainly by Gram-negative pathogens (14/26, 53.8%). Eleven patients were diagnosed with putative invasive aspergillosis. At multivariable analysis, factors associated with secondary infections were low baseline lymphocyte count (≤0.7 versus >0.7 per 109/L, subdistribution hazard ratios (sdHRs) 1.93, 95%CI 1.11-3.35), baseline PaO2/FiO2 (per 100 points lower: sdHRs 1.56, 95%CI 1.21-2.04), and intensive-care unit (ICU) admission in the first 48 hours (sdHR 2.51, 95%CI 1.04-6.05). CONCLUSIONS: Patients hospitalized with COVID-19 had a high incidence of secondary infections. At multivariable analysis, early need for ICU, respiratory failure, and severe lymphopenia were identified as risk factors for secondary infections.
引用
- Ripa M, Galli L, Poli A, et al. Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors. Clin Microbiol Infect. 2020. PMID: 33223114. doi:10.1016/j.cmi.2020.10.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。